T. Rowe Price Associates’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.42B | Buy |
7,518,742
+28,392
| +0.4% | +$5.98M | 0.16% | 123 |
|
|
2025
Q4 | $1.49B | Buy |
7,490,350
+119,809
| +2% | +$24.2M | 0.16% | 119 |
|
|
2025
Q3 | $1.5B | Buy |
7,370,541
+144,704
| +2% | +$25.7M | 0.16% | 114 |
|
|
2025
Q2 | $1.27B | Sell |
7,225,837
-370,707
| -5% | -$55.8M | 0.14% | 139 |
|
|
2025
Q1 | $1.02B | Buy |
7,596,544
+463,552
| +6% | +$61M | 0.13% | 160 |
|
|
2024
Q4 | $900M | Sell |
7,132,992
-335,380
| -4% | -$49.9M | 0.1% | 181 |
|
|
2024
Q3 | $1.24B | Sell |
7,468,372
-552,140
| -7% | -$83.5M | 0.14% | 143 |
|
|
2024
Q2 | $1.07B | Buy |
8,020,512
+105,512
| +1% | +$12.7M | 0.13% | 152 |
|
|
2024
Q1 | $832M | Buy |
7,915,000
+790,684
| +11% | +$71M | 0.1% | 184 |
|
|
2023
Q4 | $538M | Buy |
7,124,316
+1,810,993
| +34% | +$115M | 0.07% | 249 |
|
|
2023
Q3 | $350M | Buy |
5,313,323
+5,238,768
| +7,027% | +$392M | 0.05% | 295 |
|
|
2023
Q2 | $6.07M | Buy |
74,555
+21,560
| +41% | +$1.53M | ﹤0.01% | 1157 |
|
|
2023
Q1 | $3.15M | Buy |
52,995
+638
| +1% | +$35.5K | ﹤0.01% | 1310 |
|
|
2022
Q4 | $2.55M | Buy |
52,357
+1,170
| +2% | +$54.1K | ﹤0.01% | 1381 |
|
|
2022
Q3 | $2.64M | Buy |
51,187
+432
| +0.9% | +$25.6K | ﹤0.01% | 1346 |
|
|
2022
Q2 | $2.67M | Sell |
50,755
-2,820
| -5% | -$196K | ﹤0.01% | 1536 |
|
|
2022
Q1 | $4.61M | Buy |
53,575
+2,098
| +4% | +$172K | ﹤0.01% | 1477 |
|
|
2021
Q4 | $4.21M | Sell |
51,477
-1,826
| -3% | -$133K | ﹤0.01% | 1518 |
|
|
2021
Q3 | $3.54M | Sell |
53,303
-4,947
| -8% | -$351K | ﹤0.01% | 1562 |
|
|
2021
Q2 | $3.9M | Sell |
58,250
-562
| -1% | -$34.9K | ﹤0.01% | 1558 |
|
|
2021
Q1 | $3.06M | Sell |
58,812
-2,408
| -4% | -$122K | ﹤0.01% | 1577 |
|
|
2020
Q4 | $2.44M | Sell |
61,220
-5,988
| -9% | -$193K | ﹤0.01% | 1573 |
|
|
2020
Q3 | $1.65M | Buy |
67,208
+594
| +0.9% | +$15.2K | ﹤0.01% | 1608 |
|
|
2020
Q2 | $1.21M | Buy |
66,614
+713
| +1% | +$14K | ﹤0.01% | 1702 |
|
|
2020
Q1 | $949K | Buy |
65,901
+10,400
| +19% | +$299K | ﹤0.01% | 1721 |
|
|
2019
Q4 | $2.11M | Buy |
55,501
+3,878
| +8% | +$116K | ﹤0.01% | 1584 |
|
|
2019
Q3 | $1.14M | Buy |
51,623
+521
| +1% | +$11.1K | ﹤0.01% | 1757 |
|
|
2019
Q2 | $1.06M | Buy |
51,102
+5,131
| +11% | +$118K | ﹤0.01% | 1827 |
|
|
2019
Q1 | $1.33M | Sell |
45,971
-2,470
| -5% | -$61K | ﹤0.01% | 1726 |
|
|
2018
Q4 | $830K | Buy |
48,441
+11,146
| +30% | +$270K | ﹤0.01% | 1881 |
|
|
2018
Q3 | $1.06M | Buy |
37,295
+6,800
| +22% | +$225K | ﹤0.01% | 1864 |
|
|
2018
Q2 | $1.02M | Buy |
30,495
+5,633
| +23% | +$175K | ﹤0.01% | 1828 |
|
|
2018
Q1 | $603K | Buy |
24,862
+184
| +0.7% | +$3.66K | ﹤0.01% | 2012 |
|
|
2017
Q4 | $374K | Sell |
24,678
-19,012
| -44% | -$268K | ﹤0.01% | 2199 |
|
|
2017
Q3 | $718K | Hold |
43,690
| – | – | ﹤0.01% | 1933 |
|
|
2017
Q2 | $845K | Buy |
43,690
+34
| +0.1% | +$593 | ﹤0.01% | 1849 |
|
|
2017
Q1 | $773K | Buy |
43,656
+10
| +0% | +$185 | ﹤0.01% | 1891 |
|
|
2016
Q4 | $648K | Buy |
43,646
+4,800
| +12% | +$86.1K | ﹤0.01% | 1948 |
|
|
2016
Q3 | $880K | Buy |
38,846
+10,400
| +37% | +$271K | ﹤0.01% | 1788 |
|
|
2016
Q2 | $786K | Sell |
28,446
-152,529
| -84% | -$4.51M | ﹤0.01% | 1784 |
|
|
2016
Q1 | $5.24M | Sell |
180,975
-1,043,744
| -85% | -$27.2M | ﹤0.01% | 1391 |
|
|
2015
Q4 | $37.1M | Sell |
1,224,719
-357,910
| -23% | -$11.7M | 0.01% | 876 |
|
|
2015
Q3 | $58.4M | Sell |
1,582,629
-13,440
| -0.8% | -$694K | 0.01% | 722 |
|
|
2015
Q2 | $92.4M | Sell |
1,596,069
-490,381
| -24% | -$25M | 0.02% | 623 |
|
|
2015
Q1 | $103M | Buy |
2,086,450
+91,790
| +5% | +$4.29M | 0.02% | 595 |
|
|
2014
Q4 | $101M | Buy |
1,994,660
+29,700
| +2% | +$1.55M | 0.02% | 615 |
|
|
2014
Q3 | $117M | Sell |
1,964,960
-4,700
| -0.2% | -$262K | 0.03% | 556 |
|
|
2014
Q2 | $92.5M | Sell |
1,969,660
-7,200
| -0.4% | -$325K | 0.02% | 658 |
|
|
2014
Q1 | $84.6M | Buy |
1,976,860
+253,090
| +15% | +$11.2M | 0.02% | 684 |
|
|
2013
Q4 | $72.6M | Sell |
1,723,770
-372,600
| -18% | -$16.2M | 0.02% | 707 |
|
|
2013
Q3 | $86.3M | Buy |
2,096,370
+23,600
| +1% | +$987K | 0.02% | 631 |
|
|
2013
Q2 | $95.6M | Buy |
+2,072,770
| New | +$92.8M | 0.03% | 589 |
|
Other funds holding THC
VPM
VCM
LPC
T. Rowe Price Associates's THC Position: Q1 2026 in Review
T. Rowe Price Associates increased its Tenet Healthcare (THC) stake by 0.38% in Q1 2026, buying an estimated $5.98M and bringing the position to 7,518,742 shares worth $1.42B. The position accounts for 0.16% of the portfolio, ranked #123.
T. Rowe Price Associates first reported a position in THC in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.5B in Q3 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.
- T. Rowe Price Associates held 7,518,742 shares of Tenet Healthcare worth $1.42B as of Q1 2026.
- T. Rowe Price Associates bought 28,392 Tenet Healthcare shares in Q1 2026, an estimated $5.98M.
- Tenet Healthcare made up 0.16% of T. Rowe Price Associates's portfolio in Q1 2026, its #123 holding.
- T. Rowe Price Associates first reported a position in Tenet Healthcare in Q2 2013 and has held it in 52 quarters since.
- T. Rowe Price Associates's Tenet Healthcare position peaked at $1.5B in Q3 2025.
- 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.